Menu
GWAS Study

Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways.

Watanabe K, Jansen PR, Savage JE et al.

35835914 PubMed ID
GWAS Study Type
2365010 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

WK
Watanabe K
JP
Jansen PR
SJ
Savage JE
NP
Nandakumar P
WX
Wang X
HD
Hinds DA
GJ
Gelernter J
LD
Levey DF
PR
Polimanti R
SM
Stein MB
VS
Van Someren EJW
SA
Smit AB
PD
Posthuma D
Chapter II

Abstract

Summary of the research findings

Insomnia is a heritable, highly prevalent sleep disorder for which no sufficient treatment currently exists. Previous genome-wide association studies with up to 1.3 million subjects identified over 200 associated loci. This extreme polygenicity suggested that many more loci remain to be discovered. The current study almost doubled the sample size to 593,724 cases and 1,771,286 controls, thereby increasing statistical power, and identified 554 risk loci (including 364 novel loci). To capitalize on this large number of loci, we propose a novel strategy to prioritize genes using external biological resources and functional interactions between genes across risk loci. Of all 3,898 genes naively implicated from the risk loci, we prioritize 289 and find brain-tissue expression specificity and enrichment in specific gene sets of synaptic signaling functions and neuronal differentiation. We show that this novel gene prioritization strategy yields specific hypotheses on underlying mechanisms of insomnia that would have been missed by traditional approaches.

593,724 European ancestry cases, 1,771,286 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

2365010
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.